BRISTOL-MYERS SQUIBB COMPANY Earnings Per Share (Basic)
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Earnings Per Share (Basic) of $1.62 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY earnings per share, basic for the quarter ending 2026-06-30 was $1.62, a 153.13% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY earnings per share, basic for the quarter ending 2026-03-31 was $1.31, a 8.26% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY earnings per share, basic for the quarter ending 2025-09-30 was $1.08, a 80.00% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY earnings per share, basic for the quarter ending 2025-06-30 was $0.64, a 22.89% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY earnings per share, basic for fiscal 2025 was $3.47.
- BRISTOL-MYERS SQUIBB COMPANY earnings per share, basic for fiscal 2024 was -$4.41, a 213.66% decline from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY earnings per share, basic for fiscal 2023 was $3.88, a 30.64% increase from fiscal 2022.
- BRISTOL-MYERS SQUIBB COMPANY earnings per share, basic for fiscal 2022 was $2.97, a 5.71% decline from fiscal 2021.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.62 10-Q · filed 2026-07-30 | $2.94 10-Q · filed 2026-07-30 | ||
| 2026-03-31 | $1.31 10-Q · filed 2026-04-30 | |||
| 2025-12-31 | $3.47 10-K · filed 2026-02-11 | |||
| 2025-09-30 | $1.08 10-Q · filed 2025-10-30 | $2.93 10-Q · filed 2025-10-30 | ||
| 2025-06-30 | $0.64 10-Q · filed 2026-07-30 | $1.85 10-Q · filed 2026-07-30 | ||
| 2025-03-31 | $1.21 10-Q · filed 2026-04-30 | |||
| 2024-12-31 | -$4.41 10-K · filed 2026-02-11 | |||
| 2024-09-30 | $0.60 10-Q · filed 2025-10-30 | -$4.45 10-Q · filed 2025-10-30 | ||
| 2024-06-30 | $0.83 10-Q · filed 2025-07-31 | -$5.05 10-Q · filed 2025-07-31 | ||
| 2024-03-31 | -$5.89 10-Q · filed 2025-04-24 | |||
| 2023-12-31 | $3.88 10-K · filed 2026-02-11 | |||
| 2023-09-30 | $0.94 10-Q · filed 2024-10-31 | $3.01 10-Q · filed 2024-10-31 | ||
| 2023-06-30 | $0.99 10-Q · filed 2024-07-26 | $2.07 10-Q · filed 2024-07-26 | ||
| 2023-03-31 | $1.08 10-Q · filed 2024-04-25 | |||
| 2022-12-31 | $2.97 10-K · filed 2025-02-12 | |||
| 2022-09-30 | $0.75 10-Q · filed 2023-10-26 | $2.01 10-Q · filed 2023-10-26 | ||
| 2022-06-30 | $0.67 10-Q · filed 2023-07-27 | $1.26 10-Q · filed 2023-07-27 | ||
| 2022-03-31 | $0.60 10-Q · filed 2023-04-27 | |||
| 2021-12-31 | $3.15 10-K · filed 2024-02-13 | |||
| 2021-09-30 | $0.70 10-Q · filed 2022-10-26 | $2.08 10-Q · filed 2022-10-26 | ||
| 2021-06-30 | $0.47 10-Q · filed 2022-07-27 | $1.38 10-Q · filed 2022-07-27 | ||
| 2021-03-31 | $0.90 10-Q · filed 2022-04-29 | |||
| 2020-12-31 | -$4.45 10-K · filed 2021-02-10 | -$3.99 10-K · filed 2023-02-14 | ||
| 2020-09-30 | $0.83 10-Q · filed 2021-10-27 | $0.45 10-Q · filed 2021-10-27 | ||
| 2020-06-30 | -$0.04 10-Q · filed 2021-07-28 | -$0.38 10-Q · filed 2021-07-28 | ||
| 2020-03-31 | -$0.34 10-Q · filed 2021-04-29 | |||
| 2019-12-31 | -$0.55 10-K · filed 2021-02-10 | $2.02 10-K · filed 2022-02-09 | ||
| 2019-09-30 | $0.83 10-K · filed 2021-02-10 | $2.75 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $0.88 10-K · filed 2021-02-10 | $1.92 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $1.05 10-K · filed 2021-02-10 | |||
| 2018-12-31 | $0.71 10-K · filed 2020-02-24 | $3.01 10-K · filed 2021-02-10 | ||
| 2018-09-30 | $1.16 10-K · filed 2020-02-24 | $2.30 10-Q · filed 2019-10-31 | ||
| 2018-06-30 | $0.23 10-K · filed 2020-02-24 | $1.14 10-Q · filed 2019-07-25 | ||
| 2018-03-31 | $0.91 10-K · filed 2020-02-24 | |||
| 2017-12-31 | -$1.42 10-K · filed 2019-02-25 | $0.61 10-K · filed 2020-02-24 | ||
| 2017-09-30 | $0.52 10-K · filed 2019-02-25 | $2.02 10-Q · filed 2018-10-25 | ||
| 2017-06-30 | $0.56 10-K · filed 2019-02-25 | $1.51 10-Q · filed 2018-07-26 | ||
| 2017-03-31 | $0.95 10-K · filed 2019-02-25 | |||
| 2016-12-31 | $0.53 10-K · filed 2018-02-13 | $2.67 10-K · filed 2019-02-25 | ||
| 2016-09-30 | $0.72 10-K · filed 2018-02-13 | $2.13 10-Q · filed 2017-10-26 | ||
| 2016-06-30 | $0.70 10-K · filed 2018-02-13 | $1.41 10-Q · filed 2017-07-27 | ||
| 2016-03-31 | $0.72 10-K · filed 2018-02-13 | |||
| 2015-12-31 | -$0.12 10-K · filed 2017-02-21 | $0.94 10-K · filed 2018-02-13 | ||
| 2015-09-30 | $0.42 10-K · filed 2017-02-21 | $1.06 10-Q · filed 2016-10-27 | ||
| 2015-06-30 | -$0.08 10-K · filed 2017-02-21 | $0.63 10-Q · filed 2016-07-28 | $0.64 derived: net income ÷ weighted average shares · filed 2017-02-21 | $1.08 derived: net income ÷ weighted average shares · filed 2017-02-21 |
| 2015-03-31 | $0.71 10-K · filed 2017-02-21 | $0.72 derived: net income ÷ weighted average shares · filed 2017-02-21 | $1.16 derived: net income ÷ weighted average shares · filed 2017-02-21 | $1.36 derived: net income ÷ weighted average shares · filed 2017-02-21 |
| 2014-12-31 | $0.01 10-K · filed 2016-02-12 | $0.44 derived: net income ÷ weighted average shares · filed 2017-02-21 | $0.64 derived: net income ÷ weighted average shares · filed 2017-02-21 | $1.21 10-K · filed 2017-02-21 |
| 2014-09-30 | $0.43 10-K · filed 2016-02-12 | $0.64 derived: net income ÷ weighted average shares · filed 2015-10-27 | $1.20 10-Q · filed 2015-10-27 | $1.64 derived: net income ÷ weighted average shares · filed 2016-02-12 |
| 2014-06-30 | $0.20 10-K · filed 2016-02-12 | $0.77 10-Q · filed 2015-07-23 | $1.21 derived: net income ÷ weighted average shares · filed 2016-02-12 | $1.63 derived: net income ÷ weighted average shares · filed 2016-02-12 |
| 2014-03-31 | $0.57 10-K · filed 2016-02-12 | $1.01 derived: net income ÷ weighted average shares · filed 2016-02-12 | $1.43 derived: net income ÷ weighted average shares · filed 2016-02-12 | $1.76 derived: net income ÷ weighted average shares · filed 2016-02-12 |
| 2013-12-31 | $0.44 10-K · filed 2015-02-13 | $0.86 derived: net income ÷ weighted average shares · filed 2016-02-12 | $1.19 derived: net income ÷ weighted average shares · filed 2016-02-12 | $1.56 10-K · filed 2016-02-12 |
| 2013-09-30 | $0.42 10-K · filed 2015-02-13 | $0.75 derived: net income ÷ weighted average shares · filed 2014-10-24 | $1.12 10-Q · filed 2014-10-24 | $1.68 derived: net income ÷ weighted average shares · filed 2015-02-13 |
| 2013-06-30 | $0.33 10-K · filed 2015-02-13 | $0.70 10-Q · filed 2014-07-24 | $1.26 derived: net income ÷ weighted average shares · filed 2015-02-13 | $0.82 derived: net income ÷ weighted average shares · filed 2015-02-13 |
| 2013-03-31 | $0.37 10-K · filed 2015-02-13 | $0.94 derived: net income ÷ weighted average shares · filed 2015-02-13 | $0.50 derived: net income ÷ weighted average shares · filed 2015-02-13 | $0.89 derived: net income ÷ weighted average shares · filed 2015-02-13 |
| 2012-12-31 | $0.56 10-K · filed 2014-02-14 | $0.13 derived: net income ÷ weighted average shares · filed 2015-02-13 | $0.52 derived: net income ÷ weighted average shares · filed 2015-02-13 | $1.17 10-K · filed 2015-02-13 |
| 2012-09-30 | -$0.43 10-K · filed 2014-02-14 | -$0.04 derived: net income ÷ weighted average shares · filed 2013-10-23 | $0.62 10-Q · filed 2013-10-23 | $1.12 derived: net income ÷ weighted average shares · filed 2014-02-14 |
| 2012-06-30 | $0.38 10-K · filed 2014-02-14 | $1.04 10-Q · filed 2013-07-25 | $1.54 derived: net income ÷ weighted average shares · filed 2014-02-14 | $2.11 derived: net income ÷ weighted average shares · filed 2014-02-14 |
| 2012-03-31 | $0.65 10-K · filed 2014-02-14 | $1.15 derived: net income ÷ weighted average shares · filed 2014-02-14 | $1.72 derived: net income ÷ weighted average shares · filed 2014-02-14 | $2.25 derived: net income ÷ weighted average shares · filed 2014-02-14 |
| 2011-12-31 | $0.50 10-K · filed 2013-02-15 | $1.07 derived: net income ÷ weighted average shares · filed 2014-02-14 | $1.60 derived: net income ÷ weighted average shares · filed 2014-02-14 | $2.18 10-K · filed 2014-02-14 |
| 2011-09-30 | $0.57 10-K · filed 2013-02-15 | $1.10 derived: net income ÷ weighted average shares · filed 2012-10-24 | $1.67 10-Q · filed 2012-10-24 | $1.96 derived: net income ÷ weighted average shares · filed 2013-02-15 |
| 2011-06-30 | $0.53 10-K · filed 2013-02-15 | $1.11 10-Q · filed 2012-07-25 | $1.39 derived: net income ÷ weighted average shares · filed 2013-02-15 | $1.94 derived: net income ÷ weighted average shares · filed 2013-02-15 |
| 2011-03-31 | $0.58 10-K · filed 2013-02-15 | $0.86 derived: net income ÷ weighted average shares · filed 2013-02-15 | $1.41 derived: net income ÷ weighted average shares · filed 2013-02-15 | $1.95 derived: net income ÷ weighted average shares · filed 2013-02-15 |
| 2010-12-31 | $0.28 10-K · filed 2012-02-17 | $0.83 derived: net income ÷ weighted average shares · filed 2013-02-15 | $1.37 derived: net income ÷ weighted average shares · filed 2013-02-15 | $1.80 10-K · filed 2013-02-15 |
| 2010-09-30 | $0.55 10-K · filed 2012-02-17 | $1.09 derived: net income ÷ weighted average shares · filed 2011-10-27 | $1.52 10-Q · filed 2011-10-27 | |
| 2010-06-30 | $0.54 10-K · filed 2012-02-17 | $0.97 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $0.43 10-K · filed 2012-02-17 | |||
| 2009-12-31 | $4.08 10-K · filed 2011-02-18 | $5.35 10-K · filed 2012-02-17 | ||
| 2009-09-30 | $0.49 10-K · filed 2011-02-18 | $1.30 10-Q · filed 2010-10-26 | ||
| 2009-06-30 | $0.49 10-K · filed 2011-02-18 | $0.81 10-Q · filed 2010-07-22 | ||
| 2009-03-31 | $0.32 10-K · filed 2011-02-18 | |||
| 2008-12-31 | $2.64 10-K · filed 2011-02-18 | |||
| 2008-09-30 | $1.30 10-Q · filed 2009-10-22 | $2.02 10-Q · filed 2009-10-22 | ||
| 2008-06-30 | $0.38 10-Q · filed 2009-07-23 | $0.72 10-Q · filed 2009-07-23 | ||
| 2007-12-31 | $1.09 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |